Am J Obstet Gynecol

1. MORO F, Pinto AP, Chiappa V, Testa AC, et al
   Prediction of non-resectability using the updated Predictive Index Value model assessed by imaging and surgery in tubo-ovarian cancer: a prospective multicenter ISAAC study.
   Am J Obstet Gynecol. 2024 Jul 3:S0002-9378(24)00740.
   

   >> Share

   
   

   
   BMC Cancer

2. RUBIO MJ, Manzano A, de Sande LM, Estevez-Garcia P, et al
   Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study.
   BMC Cancer. 2024;24:803.
   

   >> Share

   
   

   
   Curr Treat Options Oncol

3. GONZALEZ A, Nagel CI, Haight PJ
   Targeted Therapies in Low-Grade Serous Ovarian Cancers.
   Curr Treat Options Oncol. 2024;25:854-868.
   

   >> Share

   
   

   
   Gynecol Oncol

4. ANDRES S, Finch L, Iasonos A, Zhou Q, et al
   Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer.
   Gynecol Oncol. 2024;189:30-36.
   

   >> Share

   
   
5. MAHONEY DE, Mukherjee R, Thompson J
   Elucidating the influences of social determinants of health on perceived overall health among African American/Black and Hispanic ovarian cancer survivors using the NIH All of Us Research Program.
   Gynecol Oncol. 2024;189:24-29.
   

   >> Share

   
   

   
   PLoS One

6. ZHAO S, Wang L, Ouyang M, Xing S, et al
   Polyploid giant cancer cells induced by Docetaxel exhibit a senescence phenotype with the expression of stem cell markers in ovarian cancer cells.
   PLoS One. 2024;19:e0306969.
   

   >> Share

   
   
7. ANCHOORI RK, Tseng SH, Tsai HL, Palande V, et al
   Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer.
   PLoS One. 2024;19:e0305710.
   

   >> Share

   
   
8. MA MC, Lavi ES, Altwerger G, Lin ZP, et al
   Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patients.
   PLoS One. 2024;19:e0305273.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share